In 2015 and 2016, an unusually large number of babies in a neonatal unit in northern England died. In two trials, one lasting 10 months over 2022 and 2023 and the other concluding in July 2024, a ...

Catherine, Princess of Wales has spoken of her experience with cancer, in a deeply personal video message released Wednesday to mark World Cancer Day. Kate, 44, who is now in remission after she was ...

Before he was the subject of a hit Netflix documentary, Alex Honnold was the focus of a National Geographic special, “Free Solo.” It is currently available on Disney Plus, which is the official home ...

André Ricciardi shares his final journey after being diagnosed with colon cancer in the documentary 'André Is an Idiot' André Ricciardi calls himself a “f---ing idiot” for not getting a colonoscopy ...

Add Yahoo as a preferred source to see more of our stories on Google. “This film embraces the messiness of being alive and chooses laughter over fear,” director Tony Benna tells PEOPLE exclusively His ...

André Ricciardi calls himself a “f---ing idiot” for not getting a colonoscopy when he turned 50 He was eventually diagnosed with terminal colon cancer and decided to share his journey in the ...

His friends and family praise him as unique, funny, and talented, but according to André Ricciardi, he’s a “f---ing idiot.” Armed with dark humor — and a camera crew — Ricciardi faces cancer and comes ...

A 15-year agreement between the UK Nuclear Decommissioning Authority and biotech firm Bicycle Therapeutics focuses on securing the medical isotope lead-212 from the UK's stockpile of reprocessed ...

LONDON, Dec 12 (Reuters) - King Charles said on Friday that his doctors can reduce his treatment for cancer in the new year, describing the moment as a "blessing" and testament to remarkable medical ...

Britain’s King Charles III offered a rare update on his cancer journey in a video message on Friday evening, revealing that he has responded well to treatment and it will be reduced in the new year.

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved tisotumab vedotin (Genmab AS) for adults with recurrent or metastatic cervical cancer. The decision, made via the ...